Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...
FDA approves first rapid-acting insulin
According to the FDA, the medication quickly helps to lower mealtime blood sugar spikes to improve control of blood sugar in ...
What’s the Difference Between the FDA and the USDA?
Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F. Kennedy Jr. is involved ...
IRadimed projects $78M-$82M revenue for FY2025 amid strong pump demand and FDA clearance timelines
IRadimed Corporation achieves record Q4 2024 revenue, driven by IV pump demand and monitor sales focus. Learn about their growth strategy & 2025 outlook.
60 Degrees says FDA does not object to tafenoquine import plan
Degrees Pharmaceuticals (SXTP) announced that the United States Food and Drug Administration does not object to the company’s plan to import ...
ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community
FORT LAUDERDALE, FL / ACCESSWIRE / February 11, 2025 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a clinical-stage biopharmaceutical company fo ...
BlinkLab initiates first US clinical sites for autism registrational study
Two leading US-based autism centres have joined BlinkLab’s autism diagnostic registrational trial with the paediatric ...